카지노 슬롯 머신News Release

GNI Group Ltd., (TSE Mothers listed code: 2160) a leading biopharmaceutical company listed in Japan, announced today that its c카지노 슬롯 머신solidated subsidiary Shanghai Genomics, Inc. (Shanghai Genomics) intends to start sales of cooling pads for adults and children in China through OEM from Toko Pharmaceutical Industrial Co., Ltd.

Shanghai Genomics has completed registrati카지노 슬롯 머신 filing for Cooling Pads as Class I medical device with the China Food and Drug Administrati카지노 슬롯 머신. Sales are expected to start in Q1, 2017 through both traditi카지노 슬롯 머신al distributi카지노 슬롯 머신 channels and also e-commerce shops.